New ovarian cancer test twice as effective as existing methods

Fourteen-year global trial finds 86% of women can be diagnosed correctly by tracking level of protein in blood

A new screening test that tracks changing levels of a protein in the blood can detect twice as many ovarian cancers as conventional methods, research has shown.

The technique relies on a statistical calculation to interpret variations in the level of a protein called CA125 which is linked to ovarian cancer.